• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Transplantation followed by antiviral therapy cured hepatitis C in 100 percent of patients receiving kidneys from infected donors

byCaitlyn HuiandDeepti Shroff Karhade
August 8, 2018
in Chronic Disease, Gastroenterology, Surgery
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. All 20 patients included in the study were cured of HCV following antiviral therapy.

2. Similar eGFR scores were found between nontransplant and transplant patients. 

Evidence Rating Level: 2 (Good)

Study Rundown: The wait for kidney transplantation remains long, exceeding five years in many areas of the United States. While kidney transplantation extends life and improves quality of life for patients in need of transplant, 5 to 8% of eligible patients die while waiting. One proposed solution to the scarcity of available kidneys for transplant involves utilizing HCV infected kidneys, followed by HCV treatment. The authors of this study evaluated 12-month HCV treatment outcomes for participants that underwent kidney transplants with HCV infected kidneys (genotype 1) and received elbasvir-grazoprevir on posttransplant day 3. The main limitation of this study was the small sample size of 20 transplant candidates. Further studies would be needed to evaluate generalizability of these results. Overall, it was observed that 100 per cent of the patients in the study that received HCV-infected kidneys and were treated by antiviral therapy were cured of the hepatitis C.

Click to read the study in Annals of Internal Medicine

Relevant Reading: Treatment of Hepatitis C Infection in Renal Transplant Recipients: The Long Wait Is Over

In-Depth [nonrandomized trial]: The authors conducted a single-group clinical trial at the Hospital of the University of Pennsylvania. A total of 20 HCV-negative transplant candidates were included in the trial. Outcomes consisted of HCV cure, as well as estimated glomerular filtration rate (eGFR) and quality of life for the 10 kidney recipients in the trial. Within the trial, 100% of participants were cured following antiviral therapy. GFR scores were similar between HCV-kidney transplant patients and matched recipients. The median GFR score was 67.5ml/min/1.73m2 in transplant patients compared to 66.2ml/min/1.73m2 for non-transplant patients (95% CI). No patients received allograft rejection, and 2 developed de novo donor-specific antibodies that remained detectable at the last study follow-up.

RELATED REPORTS

Accessible hepatitis C care for people who inject drugs provide significantly higher rates of cure compared to conventional care

Demographic trends associated with increased maternal & neonatal Hepatitis C cases over 10 years

Adenovirus encoding hepatitis C virus vaccine is safe but effectiveness is unclear

Image: PD

©2018 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Chronic Hepatitishepatitis C
Previous Post

Idiopathic inflammatory myositis linked to statin exposure

Next Post

Dengue serostatus impacts vaccine safety

RelatedReports

Large spike in drug use-associated infective endocarditis linked with opioid epidemic
Gastroenterology

Accessible hepatitis C care for people who inject drugs provide significantly higher rates of cure compared to conventional care

March 17, 2022
Social networks play key roles in parental vaccination decisions
Chronic Disease

Demographic trends associated with increased maternal & neonatal Hepatitis C cases over 10 years

November 1, 2021
Compliance-linked incentives increase infant immunizations rates in rural India
Infectious Disease

Adenovirus encoding hepatitis C virus vaccine is safe but effectiveness is unclear

February 10, 2021
Screening insufficient for newborns exposed to hepatitis C virus
Cardiology

Expanding heart transplant in the era of direct-acting antiviral therapy for hepatitis C

December 28, 2019
Next Post
Compliance-linked incentives increase infant immunizations rates in rural India

Dengue serostatus impacts vaccine safety

Women internists earn less than men whether they are generalists, hospitalists, or sub-specialists

Classics Series, Landmark Trials in Medicine

Anastrazole superior to tamoxifen for breast cancer treatment [Classics Series]

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Severe actinic keratosis and need for additional treatment are markers for an increased risk of cutaneous squamous cell carcinoma
  • Virtual yoga and meditation intervention may be associated with increased health-related quality of life
  • Wellness Check: Mental Health
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.